These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26215677)

  • 1. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
    Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
    Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
    Magnani L; Ballantyne EB; Zhang X; Lupien M
    PLoS Genet; 2011 Nov; 7(11):e1002368. PubMed ID: 22125492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
    Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
    Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
    Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
    Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 9. ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.
    Lin CL; Tan X; Chen M; Kusi M; Hung CN; Chou CW; Hsu YT; Wang CM; Kirma N; Chen CL; Lin CH; Lathrop KI; Elledge R; Kaklamani VG; Mitsuya K; Huang TH
    BMC Med Genomics; 2020 May; 13(1):69. PubMed ID: 32408897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
    Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
    J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
    Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
    Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.
    Zhao Z; Wang L; Xu W
    Oncogene; 2015 Mar; 34(12):1596-607. PubMed ID: 24747967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.
    Chi Y; Huang S; Wang L; Zhou R; Wang L; Xiao X; Li D; Cai Y; Zhou X; Wu J
    BMC Cancer; 2014 Aug; 14():577. PubMed ID: 25106495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
    Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
    Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread association of ERα with RMRP and tRNA genes in MCF-7 cells and breast cancers.
    Malcolm JR; Leese NK; Lamond-Warner PI; Brackenbury WJ; White RJ
    Gene; 2022 May; 821():146280. PubMed ID: 35143945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.
    Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H
    Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.